Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBITDA (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed EBITDA for 16 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 38.0% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 100.84% year-over-year, with the annual reading at $1.3 million for FY2025, 100.46% up from the prior year.
  • EBITDA hit $8.0 million in Q4 2025 for Mesa Laboratories, up from $4.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $8.0 million in Q4 2025 to a low of -$271.3 million in Q1 2024.
  • Historically, EBITDA has averaged -$12.3 million across 5 years, with a median of $3.1 million in 2021.
  • Biggest five-year swings in EBITDA: crashed 11518.18% in 2021 and later skyrocketed 8725.37% in 2024.
  • Year by year, EBITDA stood at -$2.5 million in 2021, then surged by 235.43% to $3.4 million in 2022, then crashed by 101.97% to -$67000.0 in 2023, then surged by 8725.37% to $5.8 million in 2024, then skyrocketed by 38.0% to $8.0 million in 2025.
  • Business Quant data shows EBITDA for MLAB at $8.0 million in Q4 2025, $4.7 million in Q3 2025, and $3.1 million in Q2 2025.